ABS – Board approval of share capital increase related to share option exercises
Reference is made to the stock exchange release published by Arctic Bioscience 22 February 2022 regarding exercise of share options and corresponding issuance of new shares in Arctic Bioscience.On 23 February 2022, the board of Arctic Bioscience, on the basis of a board authorization granted by the general meeting, resolved to increase the share capital from NOK 2,429,953.90, a share capital increase of by NOK 7,618 to NOK 2,437,571.90 by subscription of 76,180 new shares with a nominal value of NOK 0,10 per share, at a subscription price of NOK 9.845 per share, including a share premium of